Skip to main content

SpringWorks Therapeutics, Inc.

SWTXDelisted Jul 1, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001773427

SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding SpringWorks Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of SWTX: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders1362144+10
Shares49.5M35.8K55.3M+5.86M (+11.9%)
Value$2.79B$2.02M$1.36B−$1.43B (−51.2%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to SWTX in Q2 2022
InstitutionSharesValue% of portfolio
Nomura Holdings Inc506,772$13.4M0.12%
Cormorant Asset Management, LP475,000$11.7M0.91%
Two Sigma Investments, LP322,692$7.95M0.03%
D. E. Shaw & Co., Inc.245,463$6.04M0.01%
Two Sigma Advisers, LP148,400$3.65M0.01%
Cubist Systematic Strategies, LLC136,515$3.36M0.03%
PDT Partners, LLC88,782$2.19M0.19%
Trexquant Investment LP88,347$2.17M0.10%
UBS Oconnor LLC81,493$2.01M0.02%
Occudo Quantitative Strategies LP68,150$1.68M0.14%
Walleye Capital LLC65,949$1.62M0.05%
Millennium Management LLC63,672$1.57M0.00%
Jump Financial, LLC41,100$1.01M0.04%
Schonfeld Strategic Advisors LLC34,900$859.0K0.01%
Connor, Clark & Lunn Investment Management Ltd.32,770$807.0K0.00%
Bank of Montreal30,948$785.0K0.00%
Squarepoint Ops LLC28,068$691.0K0.01%
ExodusPoint Capital Management, LP26,921$663.0K0.01%
Man Group plc–$472.0K0.00%
MONECO Advisors, LLC17,852$440.0K0.17%
ETF Managers Group, LLC15,681$400.0K0.01%
CSS LLC12,200$300.0K0.01%
Mirae Asset Global Investments Co., Ltd.10,027$247.0K0.00%
Simplex Trading, LLC5,531$136.0K0.00%
Acuta Capital Partners, LLC5,000$123.0K0.07%
Federated Hermes, Inc.4,221$104.0K0.00%
Amundi2,678$77.0K0.00%
Group One Trading, L.P.3,014$74.0K0.00%
Quadrant Capital Group LLC164$4.00K0.00%
Ellis Investment Partners, LLC100$2.00K0.00%
Allworth Financial LP5$00.00%
Ellevest, Inc.17$00.00%
Lindbrook Capital, LLC10$00.00%

Sold out (23)

Institutions that held SpringWorks Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held SpringWorks Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SWTX in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC31,048$1.75M
Amalgamated Financial Corp.4,761$269.0K